Mirae Asset Capital Life Science Emerges From Stealth With $50M Fund

USA
Published on By
Naveen M. Krishnan, MD, MPhil is the Managing Director of Mirae Asset Capital Life Science and oversees the firm's investments, strategy, and growth. (Photo: Business Wire)
Naveen M. Krishnan, MD, MPhil is the Managing Director of Mirae Asset Capital Life Science and oversees the firm’s investments, strategy, and growth. (Photo: Business Wire)

Mirae Asset Capital Life Science, a Boston, MA- and San Francisco, CA-based venture capital firm investing in private biotechnology companies, has emerged from stealth with its inaugural $50m fund. 

Mirae Asset Capital Life Science Inception I, LP, is supported by a diverse global investor base comprised of Limited Partners within the Mirae Asset Financial Group.

Read more on VCWire.tech, our new website dedicated to the tech venture capital industry.

FinSMEs

19/01/2024